Pharmaceuticals
6 articles
Nature drug designers will create new medicines for endangered species
At a laboratory in Michigan, chemist Tim Cernak is developing a precision insecticide to protect hemlock trees from invasive species.
Boehringer's obesity drug shows efficacy, faces tolerability challenge
In a pivotal Phase 3 obesity trial, 19% of patients on Boehringer Ingelheim and Zealand Pharma's experimental drug survodutide discontinued treatment due to severe gastrointestinal side effects, a rat
Medicare's temporary $50 copay for obesity drugs like Zepbound
Starting July 1, 2026, eligible Medicare Part D beneficiaries will access branded obesity drugs like Zepbound for a $50 monthly copay, an unprecedented expansion of coverage set to expire just 18 mont
FDA Requests Additional Safety Data for Lilly's Foundayo Obesity Drug
The FDA has requested Eli Lilly conduct additional long-term safety studies for its newly approved oral obesity drug Foundayo, specifically flagging risks like heart attack, stroke, and liver injury.
Pfizer advances monthly obesity drug targeting triple hormone receptors
Pfizer is advancing a monthly weight-loss injection, danuglipron, having announced positive early-stage data.
New Quintuple Agonist Shows Promise for Obesity and Diabetes in Mice
In obese mice, a single experimental drug molecule, a GLP-1R GIPR PPAR quintuple agonist, led to greater weight loss and better blood sugar control than semaglutide (Ozempic) and a standard GLP-1/GIP